Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177

International Journal of Radiation Oncology, Biology, Physics
Sunil KrishnanNorth Central Cancer Treatment Group

Abstract

To evaluate the toxicity and maximum tolerated dose (MTD) of erlotinib plus radiation therapy (RT) in patients with glioblastoma multiforme (GBM) in a multicenter phase I trial. Patients were stratified on the basis of the use of enzyme-inducing anticonvulsants (EIACs). After resection or biopsy, patients were treated with erlotinib for 1 week before concurrent erlotinib and 6 weeks (60 Gy) of RT and maintained on erlotinib until progression. The erlotinib dose was escalated in cohorts of 3 starting at 100 mg/day. Twenty patients were enrolled and 19 were evaluable for the MTD and efficacy endpoints. Of these patients, 14 were males and 5 were females, with a median age of 54 years. Seven had undergone biopsy only, 5 had subtotal resections, and 7 had gross total resections. The highest dose level was 150 mg/day erlotinib for patients not on EIACs (Group 1) and 200 mg/day for patients on EIACs (Group 2). MTD was not reached in either group. In Group 1 at 100 mg (n=6) and at 150 mg (n=4), only 1 dose-limiting toxicity (DLT) occurred (stomatitis at 100 mg). No DLTs have occurred in Group 2 at 100 mg (n=3), 150 mg (n=3), and 200 mg (n=3). With a median follow-up of 52 weeks, progression was documented in 16 patients and 13 deaths ...Continue Reading

References

Jul 18, 1979·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·I J Selikoff
Jan 4, 1989·Journal of the National Cancer Institute·M A GerosaG Della Valle
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
Jan 15, 1994·International Journal of Cancer. Journal International Du Cancer·P H PedersenO D Laerum
Mar 1, 1996·International Journal of Radiation Oncology, Biology, Physics·A ZhuA M El-Mahdi
Nov 20, 1997·Biochimica Et Biophysica Acta·T GoldkornK Matsukuma
May 16, 1998·International Journal of Cancer. Journal International Du Cancer·S LeenstraT J Hulsebos
Nov 20, 1998·Neuropathology and Applied Neurobiology·C Bouvier-LabitD Figarella-Branger
Jan 8, 1999·Brain Tumor Pathology·N SugawaT Okabe
May 19, 2001·The New England Journal of Medicine·R S Ross, M Roggendorf
Aug 16, 2001·Journal of the National Cancer Institute·J S SmithR B Jenkins
Sep 25, 2001·International Journal of Radiation Oncology, Biology, Physics·F G BarkerK D Aldape
Nov 29, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Sunil KrishnanJann N Sarkaria
Nov 26, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeremy N RichHenry S Friedman
Jun 16, 2005·Journal of the National Cancer Institute·Daphne A Haas-KoganDavid Stokoe
Jul 21, 2005·International Journal of Radiation Oncology, Biology, Physics·Jing LiPaul M Harari
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew B LassmanEric C Holland
Nov 12, 2005·The New England Journal of Medicine·Ingo K MellinghoffPaul S Mischel
Jun 1, 2010·International Journal of Radiation Oncology, Biology, Physics·Joon H UhmKurt A Jaeckle

❮ Previous
Next ❯

Citations

Jun 30, 2009·Journal of Neuro-oncology·David A ReardonHenry S Friedman
Feb 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Nicholas J SzerlipCameron W Brennan
Oct 27, 2010·Neuro-oncology·Birgit GeoergerUNKNOWN ITCC (Innovative Therapies for Children with Cancer) European Consortium
Oct 6, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jann N SarkariaJan C Buckner
Dec 23, 2011·Radiation Oncology·Maximilian NiyaziClaus Belka
Oct 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul D BrownUNKNOWN North Central Cancer Treatment Group Study N0177
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael D PradosDaphne A Haas-Kogan
Nov 6, 2008·Expert Review of Anticancer Therapy·Javier Gonzalez, John de Groot
Jan 17, 2009·Molecular Medicine·Andreas A Argyriou, Haralabos P Kalofonos
Mar 1, 2008·Biologics : Targets & Therapy·Robin K Kelley, Andrew H Ko
Jan 1, 2009·OncoTargets and Therapy·Rimas V LukasM Kelly Nicholas
Nov 18, 2011·ISRN Oncology·Annamaria Cimini, Rodolfo Ippoliti
Feb 11, 2014·Current Oncology Reports·Mohamed Ali Hamza, Mark Gilbert
Oct 22, 2010·Investigational New Drugs·Nienke A de VriesOlaf van Tellingen
Jul 6, 2014·Journal of Neuro-oncology·Manmeet S Ahluwalia, Susan M Chang
Mar 22, 2007·Expert Opinion on Therapeutic Targets·Andrew S Chi, Patrick Y Wen
Sep 19, 2008·Growth Factors·Antony W Burgess
Dec 3, 2009·Expert Review of Neurotherapeutics·Nikhil G Thaker, Ian F Pollack
Jan 1, 2007·Expert Opinion on Drug Discovery·Sith SathornsumeteeJeremy N Rich
Aug 21, 2015·Expert Opinion on Investigational Drugs·Jennifer H Kang, Cory Adamson
Mar 7, 2008·Expert Opinion on Emerging Drugs·Warren P Mason
Aug 22, 2009·International Journal of Radiation Oncology, Biology, Physics·Masashi MizumotoKoichi Tokuuye
May 26, 2009·Seminars in Radiation Oncology·Shin-ei NodaArnab Chakravarti
Oct 22, 2008·Seminars in Oncology·Axel GrotheyUNKNOWN North Central Cancer Treatment Group
Jul 8, 2008·Critical Reviews in Oncology/hematology·Andreas A ArgyriouHaralabos P Kalofonos
Aug 12, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nicolas MagnéEric Deutsch
Oct 30, 2007·Neurologic Clinics·Robert CavaliereDavid Schiff
Nov 26, 2010·The Mount Sinai Journal of Medicine, New York·Soley Bayraktar, Caio M Rocha-Lima
Oct 19, 2006·Biochimica Et Biophysica Acta·Antonio Jimeno, Manuel Hidalgo
May 30, 2015·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Michael JuchumStefan A Laufer
Sep 24, 2014·Neuro-oncology·Robert S McNeillC Ryan Miller
Jan 1, 2009·Expert Review of Clinical Pharmacology·Rachel E Sanborn, Angela M Davies
May 24, 2007·Cancer·Sith SathornsumeteeJeremy N Rich
Nov 6, 2007·Molecular Pharmacology·Joseph N Contessa, Daniel A Hamstra
Aug 9, 2019·Cancer Chemotherapy and Pharmacology·Samuel J ReddickClinton F Stewart
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alberto BroniscerClinton F Stewart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Related Papers

The New England Journal of Medicine
Ingo K MellinghoffPaul S Mischel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
David A ReardonJeremy N Rich
Journal of the National Cancer Institute
Daphne A Haas-KoganDavid Stokoe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Paul D BrownNorth Central Cancer Treatment Group Study N0177
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Evanthia GalanisNorth Central Cancer Treatment Group
© 2022 Meta ULC. All rights reserved